FANCD2 maintains replication fork stability during misincorporation of the DNA demethylation products 5-hydroxymethyl-2'-deoxycytidine and 5-hydroxymethyl-2'-deoxyuridine.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
27 05 2022
Historique:
received: 25 10 2021
accepted: 13 05 2022
revised: 12 05 2022
entrez: 27 5 2022
pubmed: 28 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

Fanconi anemia (FA) is a rare hereditary disorder caused by mutations in any one of the FANC genes. FA cells are mainly characterized by extreme hypersensitivity to interstrand crosslink (ICL) agents. Additionally, the FA proteins play a crucial role in concert with homologous recombination (HR) factors to protect stalled replication forks. Here, we report that the 5-methyl-2'-deoxycytidine (5mdC) demethylation (pathway) intermediate 5-hydroxymethyl-2'-deoxycytidine (5hmdC) and its deamination product 5-hydroxymethyl-2'-deoxyuridine (5hmdU) elicit a DNA damage response, chromosome aberrations, replication fork impairment and cell viability loss in the absence of FANCD2. Interestingly, replication fork instability by 5hmdC or 5hmdU was associated to the presence of Poly(ADP-ribose) polymerase 1 (PARP1) on chromatin, being both phenotypes exacerbated by olaparib treatment. Remarkably, Parp1

Identifiants

pubmed: 35624090
doi: 10.1038/s41419-022-04952-0
pii: 10.1038/s41419-022-04952-0
pmc: PMC9142498
doi:

Substances chimiques

5-hydroxymethyl-2'-deoxycytidine 0
FANCD2 protein, human 0
Fanconi Anemia Complementation Group D2 Protein 0
Deoxycytidine 0W860991D6
5-hydroxymethyl-2'-deoxyuridine 5116-24-5
Thymidine VC2W18DGKR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

503

Informations de copyright

© 2022. The Author(s).

Références

Nat Chem Biol. 2014 Jul;10(7):574-81
pubmed: 24838012
EMBO J. 2009 Sep 2;28(17):2601-15
pubmed: 19629035
Nature. 2018 Jul;559(7713):285-289
pubmed: 29973717
Nat Commun. 2018 Feb 21;9(1):746
pubmed: 29467415
Mol Cell. 2018 Jul 19;71(2):319-331.e3
pubmed: 29983321
Nature. 2013 Jan 17;493(7432):356-63
pubmed: 23325218
Nat Protoc. 2012 Mar 01;7(3):594-605
pubmed: 22383038
Nat Commun. 2015 Dec 18;6:8829
pubmed: 26681308
Annu Rev Biochem. 2018 Jun 20;87:217-238
pubmed: 29298091
Nucleic Acids Res. 2013 Jul;41(13):6444-59
pubmed: 23658231
Nature. 2018 Jul;559(7713):279-284
pubmed: 29950726
Nat Rev Mol Cell Biol. 2016 Jun;17(6):337-49
pubmed: 27145721
Genes Dev. 2003 Aug 15;17(16):2021-35
pubmed: 12893777
J Cell Biol. 2019 Apr 1;218(4):1096-1107
pubmed: 30670471
Toxicol Sci. 2011 Mar;120 Suppl 1:S130-45
pubmed: 21163908
Blood. 2013 Oct 31;122(18):3206-9
pubmed: 24037726
Cell Rep. 2020 Jun 2;31(9):107705
pubmed: 32492421
Science. 2011 Sep 2;333(6047):1303-7
pubmed: 21817016
Mol Cell. 2015 Oct 1;60(1):177-88
pubmed: 26412304
Science. 2021 Apr 9;372(6538):156-165
pubmed: 33833118
Science. 2003 Jun 6;300(5625):1542-8
pubmed: 12791985
Cell Rep. 2016 Jun 14;15(11):2488-99
pubmed: 27264184
Blood. 2014 Jan 2;123(1):26-34
pubmed: 24200684
Nat Chem Biol. 2009 Jun;5(6):400-2
pubmed: 19430486
Nat Rev Dis Primers. 2019 Sep 19;5(1):64
pubmed: 31537806
Cell Rep. 2016 Feb 16;14(6):1283-1292
pubmed: 26854228
Sci Rep. 2019 Jul 30;9(1):11065
pubmed: 31363131
Nature. 2005 Apr 14;434(7035):913-7
pubmed: 15829966
Nat Struct Mol Biol. 2011 Nov 13;18(12):1432-4
pubmed: 22081012
DNA Repair (Amst). 2014 Jul;19:135-42
pubmed: 24768452
J Neurosci. 2016 Mar 02;36(9):2769-81
pubmed: 26937014
Best Pract Res Clin Haematol. 2014 Sep-Dec;27(3-4):214-21
pubmed: 25455269
Ann Hematol. 2019 Feb;98(2):271-280
pubmed: 30368588
Cell Death Differ. 2018 Nov;25(11):1967-1979
pubmed: 29511342
Cancer Cell. 2012 Jul 10;22(1):106-16
pubmed: 22789542
Cell. 2019 Jan 10;176(1-2):144-153.e13
pubmed: 30554877
Nature. 2015 Aug 6;524(7563):114-8
pubmed: 26200337
Nucleic Acids Res. 2012 Nov 1;40(20):10203-14
pubmed: 22962365
Nature. 2017 Aug 31;548(7669):549-554
pubmed: 28813411
Mutat Res. 2009 Jul 31;668(1-2):4-10
pubmed: 19622403
Nat Cell Biol. 2005 Feb;7(2):195-201
pubmed: 15665856
PLoS Biol. 2021 Mar 31;19(3):e3001176
pubmed: 33788831
Science. 2011 Sep 2;333(6047):1300-3
pubmed: 21778364
Biochemistry. 1975 Mar 25;14(6):1281-96
pubmed: 235285
Nat Cell Biol. 2014 Jan;16(1):2-9
pubmed: 24366029
Nat Rev Mol Cell Biol. 2016 Sep;17(9):553-63
pubmed: 27435505
Nucleic Acids Res. 2012 Jul;40(13):6016-25
pubmed: 22447450
Nature. 1993 Apr 22;362(6422):709-15
pubmed: 8469282
J Mol Biol. 2020 Nov 20;432(23):6157-6167
pubmed: 33065111

Auteurs

María José Peña-Gómez (MJ)

Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER) Universidad de Sevilla-CSIC-Universidad Pablo de Olavide, Seville, 41092, Spain.

Paula Moreno-Gordillo (P)

Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER) Universidad de Sevilla-CSIC-Universidad Pablo de Olavide, Seville, 41092, Spain.

Milda Narmontė (M)

Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, 10257, Lithuania.

Clara B García-Calderón (CB)

Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla/Campus Hospital Universitario Virgen del Rocío, Seville, 41013, Spain.

Audronė Rukšėnaitė (A)

Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, 10257, Lithuania.

Saulius Klimašauskas (S)

Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, 10257, Lithuania.

Iván V Rosado (IV)

Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER) Universidad de Sevilla-CSIC-Universidad Pablo de Olavide, Seville, 41092, Spain. ivrosado@us.es.
Departamento de Genética, Universidad de Sevilla, Seville, 41012, Spain. ivrosado@us.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH